Evidence map›Paper›PMID 41419941›Full record

ArticleClinical epigenetics2025

Multi-omics study of molecular and genetic bases of orthostatic hypotension.

Elena Zelenova, Veronika Daniel, Maria Bruttan, Lilya Artemieva, Ekaterina Spektor, Aleksandra Mamchur, Daria Kashtanova, Mikhail Ivanov, Gerel Abushinova, Lorena Matkava and 16 more

Abstract read
In one paragraph

Article in Clinical epigenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Elena ZelenovaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Veronika DanielFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Maria BruttanFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Lilya ArtemievaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Ekaterina SpektorFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Aleksandra MamchurFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia. almamchur98@gmail.com.
Daria KashtanovaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Mikhail IvanovFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Gerel AbushinovaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Lorena MatkavaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Antonina RumyantsevaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Aleksey IvashechkinFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Pavel GrebnevFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Liliya GolubnikovaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Sergey MitrofanovFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Anna AkopyanRussian Clinical Research Center for Gerontology of Pirogov, Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Olga BeloshevskayaRussian Clinical Research Center for Gerontology of Pirogov, Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Tatiana SaliyevaRussian Clinical Research Center for Gerontology of Pirogov, Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Irina TarasovaRussian Clinical Research Center for Gerontology of Pirogov, Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Irina StrazheskoRussian Clinical Research Center for Gerontology of Pirogov, Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Vladimir YudinFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Valentin MakarovFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Anton KeskinovFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Olga TkachevaRussian Clinical Research Center for Gerontology of Pirogov, Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Sergey YudinFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Moscow, Russia.
Veronika SkvortsovaThe Federal Medical Biological Agency (FMBA of Russia), Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orthostatic hypotension is a sharp decrease in blood pressure when an individual transitions from a supine to an upright position. OH affects at least 30% of older adults. It is attributed to the dysfunction of the autonomic innervation and decreased vascular bed capacity. Genomic (n = 2526), methylomic (n = 910), and transcriptomic (n = 391) data from centenarians aged 90 years and older were used to examine molecular and genetic factors for OH. No statistically significant genetic predictors of OH were identified. However, the study revealed numerous epigenetic markers of OH indicative of general aging, such as DNA hypomethylation. The predictive DNA methylation-based model for orthostatic hypotension demonstrated an average accuracy of 79%. The transcriptome analyses highlighted associations between OH and inflammation pathways, as well as other age-related biological processes. Integrated omics and clinical data have identified six key mechanisms associated with orthostatic hypotension: metabolic dysregulation, impaired muscle tone, altered cell proliferation, inflammation, humoral regulation, and neural regulation.

Indexed as

Hypotension, OrthostaticAged, 80 and overAgingDNA MethylationEpigenesis, GeneticEpigenomicsFemaleGene Expression ProfilingGenomicsHumansMaleMultiomicsTranscriptomeGenomicsGeriatric syndromesGWAS, EWASMachine learningMulti-omics technologiesOlder adults, DNA methylationOrthostatic hypotensionTranscriptomics

Identifiers

PMID41419941
PMCPMC12717769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.